Pharmafile Logo
Pharmafocus logo
Advanced Search

sovaldi

Showing 10 posts of 55 posts found.

Sovaldi pack shot

Gilead price lambasted by US health insurers

May 21, 2014
Medical Communications, Sales and Marketing Gilead, Incivek, Victrelis, hepatitis C, sovaldi

Gilead’s new hepatitis C pill Sovaldi is coming under more pressure in the US as health insurers hit out at …

News
Janssen logo

Europe approves Janssen’s hep C drug Olysio

May 20, 2014
Research and Development, Sales and Marketing Janssen, hepatitis C, sovaldi

Janssen-Cilag International’s Olysio has been given marketing authorisation in the European Union for the treatment of adults with hepatitis C …

News
sovaldi iamge

Sovaldi performs for Gilead

April 24, 2014
Sales and Marketing Gilead, HCV, Q1, hepatitis C, sovaldi

Gilead Sciences’ once-daily, oral hepatitis C treatment Sovaldi has returned better than expected figures in the first quarter of the …

News
merck_incweb

Merck gets hep C boost as competition ramps up

April 11, 2014
Research and Development, Sales and Marketing Merck, daclatasvir, hep C, sovaldi

Merck has released promising data from a trial which uses two of its investigational compounds to treat patients with hepatitis …

News
Gilead image

‘Compassionate’ use of hep C combo

February 24, 2014
Research and Development, Sales and Marketing CHMP, EMA, Gilead, hep C, ledipasvir, sovaldi

A key adviser to the European regulator has said that Gilead Sciences’ fixed-dose combination of Sovaldi and ledipasvir can be …

News
Sovaldi image

Gilead to allow cheaper generics of new hep C drug

February 6, 2014
Manufacturing and Production, Sales and Marketing Gilead, India, generics, hep C, s&m, sofosbuvir, sovaldi

Gilead has announced the unusual step of allowing its new and highly expensive hepatitis C pill to be sold as …

News

Europe nod for Gilead HCV pill

January 20, 2014
Sales and Marketing FDA, Gilead, HCV, hep C, sofosbuvir, sovaldi

Gilead Sciences’ once-daily, oral hepatitis C treatment Sovaldi has been given the green light by the European Commission, just a …

News
sovaldi image

Gilead’s $1,000 per day Hep C drug approved

December 9, 2013
Sales and Marketing FDA, Gilead, hepc, sofosbuvir, sovaldi

Gilead’s Sovaldi has gained FDA approval as a potential cure for hepatitis C after the US regulator sped up its …

News
Gilead image

Gilead runs into India patent trouble

November 26, 2013
Sales and Marketing Gilead, MSF, hepc, sofosbuvir, sovaldi

Gilead Sciences has run into heavy traffic in India as campaigners attempt to block the company’s patent there on new …

News

Gilead gets CHMP nod

November 25, 2013
Research and Development, Sales and Marketing CHMP, FDA, Gilead, chc, sovaldi

The CHMP has opened the way for Gilead Sciences’ first-in-class investigational chronic hepatitis C drug Sovaldi (sofosbuvir) to get to …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025